Clinical trials recruiting for Intrahepatic Cholangiocarcinoma (Icc)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
  NCT07176962 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
  NCT07632235 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
  NCT07063888 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC
  NCT06925516 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
  NCT06888063 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
  NCT07640048 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
  NCT07070700 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
  NCT06859684 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments
  NCT06862934 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
  NCT05286814 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
  NCT06852287 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
  NCT07161869 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
  NCT07337850 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury
  NCT07760038 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Scout Dose of Resin Microspheres
  NCT07476651 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
  NCT06735560 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
  NCT06721286 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Intrahepatic Cholangiocarcinoma (Icc) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Intrahepatic Cholangiocarcinoma (Icc) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.